Kadimastem Ltd (TLV:KDST)
3,490.00
0.00 (0.00%)
Oct 5, 2025, 3:49 PM IDT
Kadimastem Market Cap
Kadimastem has a market cap or net worth of 162.28 million as of October 7, 2025. Its market cap has increased by 413.56% in one year.
Market Cap
162.28M
Enterprise Value
169.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,490.00
Market Cap Chart
Since June 13, 2013, Kadimastem's market cap has increased from 72.88M to 162.28M, an increase of 122.67%. That is a compound annual growth rate of 6.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 5, 2025 | 162.28M | 201.85% |
Dec 31, 2024 | 53.76M | 116.19% |
Dec 31, 2023 | 24.87M | -37.96% |
Dec 29, 2022 | 40.08M | -66.07% |
Dec 30, 2021 | 118.12M | 197.88% |
Dec 31, 2020 | 39.65M | -27.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 75.93B |
Danel (Adir Yeoshua) | 3.10B |
Kamada | 1.31B |
Bait Bakfar | 1.01B |
BrainsWay | 977.55M |
SofWave Medical | 960.10M |
Ilex Medical | 714.47M |
Novolog (Pharm-Up 1966) | 649.83M |